参考文献/References:
1 Kassis AI, Adelstein SJ, Mariani G. Radiolabeled nucleoside analog cancer diagnosis and therapy. J Nucl Med, 1996, 40(3):301-319.
2 孙晗笑, 陆大祥, 刘飞鹏, 等.转基因技术理论与应用.郑州:河南医科大学出版社,2000.346-364.
3 Sedelnikova OA, Panyutin IG, Thierry AR, et al. Radiotoxicity of iodine-125-labeled oligodeoxyribonucleotides in mammalin cells. J Nucl Med, 1998, 39(8):1412-1418.
4 Panyutin IG, Neumann RD. Sequence-specific DNA breaks produced by triplex-directde decay of iodine-125. Acta Oncol,1996, 35(7):817-823.
5 Cammilleri S, Perdereau B, Brixy F, et al. Imaging and biodistribution of 125I tyramine oligonucleotide in nude mice bearing human breast tumor. Preliminary report. Bull Cancer Paris, 1996, 83(1):23-26.
6 刘生, 刘长征, 梁碧玲, 等.碘标记反义寡核苷酸的研究及其稳定性与生物分布的评价.核技术,2004,27(5):365-369.
7 Spitzweg C, Scholz IV, Bergert ER, et al. Retinoic acid induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells. Endaocrinology, 2003, 144(8):3423-3432.
8 Ou X, Tan T, He L, et al. Antitumor effects of radioiodinated antisense oligonuclide mediated by VIP receptor. Cancer Gene Ther, 2005, 12(3):313-320.
相似文献/References:
[1]拓飞,张庆,张京,等.2014年度全国放射性核素γ能谱分析质量控制比对[J].国际放射医学核医学杂志,2015,39(5):401.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 011]
tuo fei,zhang qing,zhang jing,et al.nationwide intercomparison for radionuclide analyses through γ-spectrometry method in 2014[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):401.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 011]
[2]李帅,李剑明.动脉粥样硬化易损斑块放射性核素标记分子探针的研究进展[J].国际放射医学核医学杂志,2015,39(1):80.[doi:10.3760/cma.j.issn.1673-4114.2015.01.017]
Li Shuai,Li Jianming.Research progress of molecular probes labeled with radionuclide for imaging of atherosclerosis vulnerable plaque[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):80.[doi:10.3760/cma.j.issn.1673-4114.2015.01.017]
[3]段钰,李斌,高卉,等.神经内分泌肿瘤PET/CT的应用现状与进展[J].国际放射医学核医学杂志,2013,37(3):186.[doi:10.3760/cma.j.issn.1673-4114.2013.03.014]
DUAN Yu,LI Bin,GAO Hui,et al.Application status and progress of PET/CT in neuroendocrine tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(3):186.[doi:10.3760/cma.j.issn.1673-4114.2013.03.014]
[4]彭武和,程静,曹庆东.核素肺通气/灌注显像在肺栓塞诊断中的现状及进展[J].国际放射医学核医学杂志,2012,36(2):80.[doi:10.3760/cma.j.issn.1673-4114.2012.02.005]
PENG Wu-he,CHENG Jing,CAO Qing-dong.Present situation and development of the nuclide lung ventilation/perfusion imaging in diagnosis of lung embolim[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(3):80.[doi:10.3760/cma.j.issn.1673-4114.2012.02.005]
[5]陈红红,白光.《人体体表放射性核素污染处理规范》解读[J].国际放射医学核医学杂志,2012,36(4):200.[doi:10.3760/cma.j.issn.1673-4114.2012.04.001]
CHEN Hong-hong,BAI Guang.Explanation of Specifwation of Decontamination for Radionuclides Contaminated Human Wound and Skin[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(3):200.[doi:10.3760/cma.j.issn.1673-4114.2012.04.001]
[6]刘庆芬,武权,樊体强,等.《放射性核素摄入量及内照射剂量估算规范》解读[J].国际放射医学核医学杂志,2012,36(4):214.[doi:10.3760/cma.j.issn.1673-4114.2012.04.005]
LIU Qing-fen,WU Quan,FAN Ti-qiang,et al.Explanation of Specification for Assessments of Intakes and Internal Doses of Radionuclides[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(3):214.[doi:10.3760/cma.j.issn.1673-4114.2012.04.005]
[7]张富海,孟召伟,谭建.肺癌的放射性核素分子靶向治疗[J].国际放射医学核医学杂志,2012,36(3):145.[doi:10.3760/cma.j.issn.1673-4114.2012.03.005]
ZHANG Fu-hai,MENG Zhao-wei,TAN Jian.Radionuclide molecular target therapy for lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(3):145.[doi:10.3760/cma.j.issn.1673-4114.2012.03.005]
[8]魏莉,罗荣城.放射性核素标记抗CD20单克隆抗体治疗B细胞淋巴瘤的研究进展[J].国际放射医学核医学杂志,2006,30(3):153.
WEI Li,LUO Rong-cheng.Advances in research of radioactive nuclide labeled anti-CD20 monoclonal antibody in B cell lymphomas[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(3):153.
[9]黄帆,高阳,张玉民,等.新型渗透性水凝胶作为载体用于肿瘤的放射性核素植入治疗[J].国际放射医学核医学杂志,2017,41(2):81.[doi:10.3760/cma.j.issn.1673-4114.2017.02.001]
Huang Fan,Gao Yang,Zhang Yumin,et al.New permeable hydrogel for tumor radiotherapy in situ[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(3):81.[doi:10.3760/cma.j.issn.1673-4114.2017.02.001]
[10]何蕊,朱高红.甲状腺髓样癌靶向治疗的研究进展[J].国际放射医学核医学杂志,2018,(2):154.[doi:10.3760/cma.j.issn.1673-4114.2018.02.010]
He Rui,Zhu Gaohong.Research status of medullary thyroid carcinoma targeted therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(3):154.[doi:10.3760/cma.j.issn.1673-4114.2018.02.010]